3rd February 2025: Tata Chemicals Limited today declared its financial results for the quarter and nine
months ended December 31, 2024.
On a consolidated basis, for the current quarter (โQ3FY25โ), the income from operations stood at โน 3,590
Cr as compared to โน 3,730 Cr in Q3FY24. EBITDA stood at โน 434 Cr as compared to โน 542 Cr in Q3FY24.
PAT (before exceptional items and non-controlling Interest (โNCIโ)) from continuing operations stood at
โน 49 Cr as compared to โน 194 Cr in Q3FY24.
On a standalone basis, for Q3FY25, the income from operations at โน 1,166 Cr as compared to โน 1,093 Cr
in Q3FY24. EBITDA at โน 209 Cr as compared to โน 206 Cr in Q3FY24. PAT at โน 72 Cr as compared to โน 115
Cr in Q3FY24.
Commenting on the results, R. Mukundan, Managing Director & CEO, Tata Chemicals Limited, said,
โOverall Asia including India continue to experience growth, while other markets including US
and Western Europe are witnessing slight decline due to reduced demand for flat and container
glass. Companyโs overall performance was down as compared to the same quarter of previous year,
mainly due to lower Soda Ash pricing across geographies and higher fixed cost in US due to plant
production outage during the quarter.Our endeavour is to maximize sales through customer engagement, while ensuring steady contribution margins with a focus on cost optimization. In the short term, current demand โ supply adverse situation is likely to persist but should improve and stabilise over the long term driven by growth sectors based on sustainability trends.โ
Consolidated Highlights Q3FY25
โ Revenue from operations stood at โน 3,590 Cr, down by 4% compared to Q3FY24, mainly on account
of adverse price movement of Soda Ash
โ EBITDA for the quarter stood at โน 434 Cr, down by 20% compared to Q3FY24.
โ Profit After Tax (before exceptional items and NCI) from continuing operations was โน 49 Cr compared
to โน 194 Cr for Q3FY24.
โ An exceptional charge of โน 70 Cr consisting of estimated expenses related to employee termination
benefits, decommissioning of plant and machinery, and other closure-related incidental expenses
was taken in Q3FY25, in relation to cessation of Soda ash production at the Lostock plant in
Northwich, UK.
โ Gross debt as on December 31, 2024, stood at โน 6,722 Cr up by โน 810 Cr and net debt at โน 5,329 Cr
up by โน 952 Cr, compared to December 31, 2023, on account of lower EBITDA and higher working
capital (US, Kenya & India).
โ 70 KTPA Pharma Salt plant commissioned in UK.
โ Sales and Production volumes of Soda Ash, Bicarb and Salt were higher than Q3FY24
Standalone Highlights Q3FY25
โ Revenue from operations stood at โน 1,166 Cr, up by 7% compared to Q3FY24.
โ EBITDA at โน 209 Cr, up by 1% compared to Q3FY24.
โ Profit After Tax from continuing operations was โน 72 Cr, down by 37% compared to Q3FY24.
โ FOS sales on track leading to full utilization of capacity.
